Jonathan Blossom, MD
Internal Medicine · Tupelo, MSNPI 1407235617
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,073 of the $10,994 with a category attached, or 82.5%. 33 manufacturers reported payments, led by Medtronic at 29.2% of the total. Reporting peaked in 2022 at $3,643 and has fallen 58.2% since, to $1,522 in 2025. Among internal medicine clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 305 payments — averaging $36.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Abiomed$1K
- Inari Medical, Inc.$801
- Penumbra, Inc.$689
- Pfizer$673
- AstraZeneca$428
- plus $4K from 27 others
Across 6 payments — averaging $11,953 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cathworks, Inc.$72K
What the payments were for
- Travel & lodging$1,74416%
- Food & beverage$9,07383%
- Education$1772%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 45 | $3,214 |
| Abiomed | 31 | $1,121 |
| Inari Medical, Inc. | 16 | $801 |
| Penumbra, Inc. | 12 | $689 |
| Pfizer | 40 | $673 |
| AstraZeneca | 18 | $428 |
| Boston Scientific | 7 | $427 |
| Abbott | 6 | $411 |
| Merck | 24 | $403 |
| Boehringer Ingelheim | 11 | $341 |
| Novartis | 20 | $317 |
| Irhythm Technologies, Inc. | 4 | $234 |
| Thrombolex, Inc. | 3 | $231 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $199 |
| W. L. Gore & Associates, Inc. | 5 | $189 |
| Amgen | 10 | $150 |
| Johnson & Johnson | 9 | $138 |
| Lantheus Medical Imaging, Inc. | 2 | $131 |
| Cardiva Medical, Inc. | 4 | $112 |
| Alnylam Pharmaceuticals Inc. | 2 | $99 |
| EKOS Corporation | 1 | $98 |
| E.r. Squibb & Sons, L.L.C. | 8 | $98 |
| Astellas Pharma US Inc | 4 | $85 |
| Edwards Lifesciences | 3 | $84 |
| Actelion Pharmaceuticals US, Inc. | 3 | $61 |
| Sanofi-aventis U.S. LLC | 1 | $59 |
| Philips North America LLC | 1 | $47 |
| Gilead | 3 | $47 |
| Novo Nordisk | 1 | $32 |
| Chiesi USA, Inc. | 2 | $28 |
| Nuwellis, Inc. | 1 | $16 |
| Akcea Therapeutics, Inc. | 1 | $15 |
| Cardiovascular Systems Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HawkOne$1,760
- FLOWTRIEVER CATHETER, S$531
- Indigo System$370
- CT THROMBECTOMY SYSTEM KIT$288
- ZIO Patch$204
- Bashir Endovascular Catheter$186
- Impella$146
- Resolute$144
- VenaSeal$144
- Definity$120
- Penumbra System$119
- SYMPLICITY G3$115
- XIENCE SIERRA$115
- ROTAPRO$113
- COREVALVE EVOLUT R$112
- GENERAL - THERAPIES$105
- FARXIGA$105
- NAVITOR$100
How this compares
$10,994 in reported general payments places this provider in the 95th percentile of 846 internal medicine providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 107 | $93,052 |
| JardianceEmpagliflozin | 98 | $67,670 |
| EliquisApixaban | 58 | $50,418 |
| FarxigaDapagliflozin Propanediol | 48 | $44,023 |
| Repatha SureclickEvolocumab | 35 | $24,287 |
| BrilintaTicagrelor | 36 | $19,135 |
| Praluent PenAlirocumab | 12 | $7,166 |
| Ranolazine ErRanolazine | 44 | $4,049 |
| Ezetimibe | 93 | $2,005 |
| Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide | 18 | $1,993 |
| Rosuvastatin Calcium | 282 | $1,986 |
| Metoprolol Succinate | 250 | $1,926 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 205 | $1,879 |
| Nitroglycerin | 61 | $1,768 |
| Atorvastatin Calcium | 233 | $1,260 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $317 | $93,052107 claims |
| Boehringer IngelheimJardiance | $341 | $67,67098 claims |
| AstraZenecaFarxiga, Brilinta | $428 | $63,15884 claims |
| PfizerEliquis | $673 | $50,41858 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 846 internal medicine providers in Mississippi.
Other internal medicine in Tupelo
- Pami TaylorTupelo$10K
- Vernon RayfordTupelo$7K
- Henry BolerTupelo$7K
- Kelly WilkinsonJackson$79K
- Shanna PettieJackson$53K
- Gabriel HernandezJackson$41K
- Indira VeerisettyRidgeland$25K
- James BridgesMadison$23K
- Brendan RossJackson$19K
- Hassan CheemaJackson$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.